|Emitents||Olainfarm, AS (213800WCG52W62ENOP27)|
|Veids||3.1. Papildu regulētā informācija, kas ir jāatklāj saskaņā ar dalībvalsts tiesību aktiem|
Olainfarm holds First Quarter 2018 Investor Conference Webinar
AS „Olainfarm” invites shareholders, investors, mass media representatives and other stakeholders to join its investor conference webinar scheduled on June 7, 2018 at 16:00 (EEST). To join the webinar please follow the instructions below.
Webinar will be hosted by the Member of the Management Board Salvis Lapiņš. The presentation will be held in English.
During the webinar Salvis Lapiņš will inform about AS “Olainfarm” latest activities and analyze the financial results of the first quarter 2018.
During the webinar the enclosed presentation will be presented.
What is webinar?
How to join the webinar?
To join the webinar, we invite you to register via http://ej.uz/OLF_Q1.
You will be provided with the webinar link and instructions to join webinar successfully. When joining the webinar for the first time, you will be asked to download the system application on your computer which will take only few seconds.
Join the webinar and be the first one to hear the news!
JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company's operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.
Information prepared by: